Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Identification of optimal site of G1 placement for median orthodromic palmar nerve conduction study
Devine, Irisa M., Rubin, Devon I.

Muscle & Nerve | September 19, 2015 | Volume: 53 | Issue: 4 | Pages: 579-582

10.1002/mus.24914 | PMID 26385132 Get It

ABSTRACTIntroduction: G1 electrode placement at the distal wrist crease during the median orthodromic palmar nerve conduction study (NCS) could result in a false negative study if compression is more proximal. Methods: In this study we aimed to determine the effect of median G1 electrode placement on distal latencies and amplitudes. Methods Median orthodromic palmar NCS was performed with the G1 electrode at the wrist crease and 2 cm proximal, stimulating 8 cm distal to G1. The difference in the distal latencies and amplitudes between the 2 recording sites was calculated. Results: In 26 controls and 25 carpal tunnel syndrome (CTS) patients, the mean proximal–distal latency difference and percent amplitude decrease (distal vs. proximal) was −0.085 ms/53% (controls) and −0.072 ms/45% (CTS). Conclusion: Distal latency is not significantly affected by G1 placement in the median orthodromic palmar NCS, but the amplitudes are nearly twice as high when G1 is placed 2 cm proximal to the wrist crease. Muscle Nerve 53: 579–582, 2016
Motion Analysis and the Anterior Cruciate Ligament: Classification of Injury Risk
Bates, Nathaniel A. , Hewett, Timothy E. , Bates, Nathaniel A

Journal of Knee Surgery | September 18, 2015 | Volume: 29 | Issue: 02 | Pages: 117-125

10.1055/s-0035-1558855 | PMID 26383143 Get It

Accuracy of annual prescription drug expenditure forecasts inAJHP
Hartke, Patricia, Vermeulen, Lee C. , Hoffman, James M. , Shah, Nilay D. , Doloresco, Fred, Suda, Katie J. , Li, Edward C., Matusiak, Linda M., Hunkler, Robert J., Schumock, Glen T., Hartke, Patricia L

American Journal of Health-System Pharmacy | September 18, 2015 | Volume: 72 | Issue: 19 | Pages: 1642-1648

10.2146/ajhp140850 | PMID 26386105 Get It

The mixed impact of medical school on medical students’ implicit and explicit weight bias
Puhl, Rebecca M. , Burke, Sara E. , Nelson, David , Przedworski, Julia , Perry, Sylvia , Yeazel, Mark W. , Ryn, Michelle van , Phelan, Sean M. , van Ryn, Michelle, Hardeman, Rachel R. , Dovidio, John F. , Burgess, Diana Jill , Perry, Sylvia P , van Ryn, Michelle

Medical Education | September 18, 2015 | Volume: 49 | Issue: 10 | Pages: 983-992

10.1111/medu.12770 | PMID 26383070 Get It

Context Health care trainees demonstrate implicit (automatic, unconscious) and explicit (conscious) bias against people from stigmatised and marginalised social groups, which can negatively influence communication and decision making. Medical schools are well positioned to intervene and reduce bias in new physicians. Objectives This study was designed to assess medical school factors that influence change in implicit and explicit bias against individuals from one stigmatised group: people with obesity. Methods This was a prospective cohort study of medical students enrolled at 49 US medical schools randomly selected from all US medical schools within the strata of public and private schools and region. Participants were 1795 medical students surveyed at the beginning of their first year and end of their fourth year. Web‐based surveys included measures of weight bias, and medical school experiences and climate. Bias change was compared with changes in bias in the general public over the same period. Linear mixed models were used to assess the impact of curriculum, contact with people with obesity, and faculty role modelling on weight bias change. Results Increased implicit and explicit biases were associated with less positive contact with patients with obesity and more exposure to faculty role modelling of discriminatory behaviour or negative comments about patients with obesity. Increased implicit bias was associated with training in how to deal with difficult patients. On average, implicit weight bias decreased and explicit bias increased during medical school, over a period of time in which implicit weight bias in the general public increased and explicit bias remained stable. Conclusions Medical schools may reduce students’ weight biases by increasing positive contact between students and patients with obesity, eliminating unprofessional role modelling by faculty members and residents, and altering curricula focused on treating difficult patients.
What would be the annual cost savings if fewer screws were used in adolescent idiopathic scoliosis treatment in the US?
Larson, A. Noelle , Polly, David W. , Ackerman, Stacey J. , Ledonio, Charles Gerald T., Lonner, Baron S. , Shah, Suken A. , Emans, John B. , Richards, B. Stephens , _, _, _, _, Larson, A Noelle , Polly, David

Journal of Neurosurgery: Spine | September 18, 2015 | Volume: 24 | Issue: 1 | Pages: 116-123

10.3171/2015.4.spine131119 | PMID 26384134 Get It

OBJECT There is substantial heterogeneity in the number of screws used per level fused in adolescent idiopathic scoliosis (AIS) surgery. Assuming equivalent clinical outcomes, the potential cost savings of using fewer pedicle screws were estimated using a medical decision model with sensitivity analysis. METHODS Descriptive analyses explored the annual costs for 5710 AIS inpatient stays using discharge data from the 2009 Kids’ Inpatient Database (Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality), which is a national all-payer inpatient database. Patients between 10 and 17 years of age were identified using the ICD-9-CM code for idiopathic scoliosis (737.30). All inpatient stays were assumed to represent 10-level fusions with pedicle screws for AIS. High screw density was defined at 1.8 screws per level fused, and the standard screw density was defined as 1.48 screws per level fused. The surgical return for screw malposition was set at $23,762. A sensitivity analysis was performed by varying the cost per screw ($600–$1000) and the rate of surgical revisions for screw malposition (0.117%–0.483% of screws; 0.8%–4.3% of patients). The reported outcomes include estimated prevented malpositioned screws (set at 5.1%), averted revision surgeries, and annual cost savings in 2009 US dollars, assuming similar clinical outcomes (rates of complications, revision) using a standard- versus high-density pattern. RESULTS The total annual costs for 5710 AIS hospital stays was $278 million ($48,900 per patient). Substituting a high for a standard screw density yields 3.2 fewer screws implanted per patient, with 932 malpositioned screws prevented and 21 to 88 revision surgeries for implant malposition averted, and a potential annual cost savings of $11 million to $20 million (4%–7% reduction in the total cost of AIS hospitalizations). CONCLUSIONS Reducing the number of screws used in scoliosis surgery could potentially decrease national AIS hospitalization costs by up to 7%, which may improve the safety and efficiency of care. However, such a screw construct must first be proven safe and effective.
Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis
Ungprasert, Patompong , Upala, Sikarin , Sanguankeo, Anawin , Warrington, Kenneth J. , Warrington, Kenneth J

Modern Rheumatology | September 18, 2015 | Volume: 26 | Issue: 3 | Pages: 410-414

10.3109/14397595.2015.1081722 | PMID 26381748 Get It

Halloysite nanotube reinforced polylactic acid composite
Chen, Yuan Yuan , Killion, John A., Lyons, John G. , Higginbotham, Clement L. , Devine, Declan M. , Geever, Luke M.

Polymer Composites | September 18, 2015 | Volume: 38 | Issue: 10 | Pages: 2166-2173

10.1002/pc.23794 Get It

Polylactic acid (PLA) has a long history in medical applications. Reinforced PLA has the potential to be used in the medical applications that require high mechanical strength such as coronary stents and bone fixation devices. Halloysite nanotube (HNT) has received considerable attention recently due to its tubular structure, high aspect ratio, high mechanical strength, thermal stability, biocompatibility and sustained drug releasing properties. Halloysite has been investigated in compounding with many polymers. However, the research in compounding halloysite with biodegradable materials for use in biological applications is sparse. In this study various weight fractions of HNT was compounded with the biodegradable polymer PLA using a melt compounding method. Tensile test, Fourier infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), contact angle test, scanning electron microscopy (SEM), void content and thermogravimetric analysis (TGA) were carried out to study the PLA/HNT composite. Tensile test results indicated that Young's modulus and stiffness of PLA were enhanced with the addition of HNT; FTIR spectra showed the interaction between the PLA and HNT; whereas contact angle measurements indicated that the wettability of the PLA/HNT composite was not affected by the addition of HNT. However, the thermal stability of PLA was adversely effected by the addition of HNT which may be related to the presence of voids between the polymer and matrix. Nevertheless, the reinforced PLA/HNT composite, which maintains the surface characteristics, may prove beneficial for use in biological applications. POLYM. COMPOS., 38:2166–2173, 2017. © 2015 Society of Plastics Engineers
FilmArray Respiratory Panel Assay: Comparison of Nasopharyngeal Swabs and Bronchoalveolar Lavage Samples
Azadeh, Natalya , Sakata, Kenneth K. , Brighton, Anjuli, Vikram, Holenarasipur R. , Grys, Thomas E. , Brighton, Anjuli M, Vikram, Holenarasipur R. , Grys, Thomas E

Journal of Clinical Microbiology | September 17, 2015 | Volume: 53 | Issue: 12 | Pages: 3784-3787

10.1128/jcm.01516-15 | PMID 26378282 Get It

ABSTRACT The FilmArray respiratory panel (FARP) reliably and rapidly identifies 17 viruses and 3 bacterial pathogens. A nasopharyngeal swab FARP (NP FARP) is performed for many patients with respiratory symptoms. For patients who are acutely ill or immunocompromised or fail to improve, a bronchoalveolar lavage sample FARP (BAL FARP) is performed in addition to the NP FARP. To date, no studies have compared the yield of a BAL FARP with that of an NP FARP. We retrospectively studied all patients who had a BAL FARP within 7 days after an NP FARP between June 2013 and May 2014. Demographic information, comorbidities, FARP results, and all microbiologic data from BAL fluid were collected. Eighty-six patients had a BAL FARP performed within 7 days (mean, 1.6; median, 1) after an NP FARP. Of these, 66 (77%) had concordant BAL and NP FARP results: 15 (23%) had the same pathogen identified from the NP and BAL FARPs, and 51 (77%) had concordant negative FARP results. In 18 of the 86 patients (21%), a pathogen was detected from the NP FARP; of these, 15 (83%) had a concordant match on a subsequent BAL FARP, and the remaining 3 had negative BAL FARPs. In 17 of the 86 patients (20%), pathogens were identified from the BAL FARPs that were not detected by the NP FARPs; of these, 16 (94%) had initial negative NP FARPs. The data suggest that once a pathogen is identified by an NP FARP, a subsequent BAL FARP is unlikely to add new microbiologic information. However, a BAL FARP may provide new, useful microbiologic information when performed within 7 days after a negative NP FARP.
Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
Kong, Sinyi, Dong, Hongxin , Thiruppathi, Muthusamy , Lin, Zhenghong , Chini, Eduardo N. , Fang, Deyu , Chini, Eduardo, Song, Jianxun Jim , Prabhakar, Bellur S. , Qiu, Quan, Zhang, Bin

The Journal of Immunology | September 17, 2015 | Volume: 195 | Issue: 8 | Pages: 3685-3693

10.4049/jimmunol.1500713 | PMID 26378077 Get It

Abstract Alternative NF-κB signaling is crucial for B cell activation and Ig production, and it is mainly regulated by the inhibitor of κ B kinase (IKK) regulatory complex. Dysregulation of alternative NF-κB signaling in B cells could therefore lead to hyperactive B cells and Ig overproduction. In our previous, study we found that deleted in breast cancer 1 (DBC1) is a suppressor of the alternative NF-κB pathway to attenuate B cell activation. In this study, we report that loss of DBC1 results in spontaneous overproduction of Ig in mice after 10 mo of age. Using a double mutant genetic model, we confirm that DBC1 suppresses B cell activation through RelB inhibition. At the molecular level, we show that DBC1 interacts with alternative NF-κB members RelB and p52 through its leucine zipper domain. In addition, phosphorylation of DBC1 at its C terminus by IKKα facilitates its interaction with RelB and IKKα, indicating that DBC1-mediated suppression of alternative NF-κB is regulated by IKKα. Our results define the molecular mechanism of DBC1 inhibition of alternative NF-κB activation in suppressing B cell activation.
Histone Deacetylases in Bone Development and Skeletal Disorders
Bradley, Elizabeth W. , Carpio, Lomeli R., Wijnen, André J. van , McGee‐Lawrence, Meghan E. , Westendorf, Jennifer J., Shull, Lomeli C. , van Wijnen, Andre J, Westendorf, Jennifer J. , van Wijnen, Andre J , Bradley, Elizabeth W , McGee-Lawrence, Meghan E

Physiological Reviews | September 17, 2015 | Volume: 95 | Issue: 4 | Pages: 1359-1381

10.1152/physrev.00004.2015 | PMID 26378079 Get It

Histone deacetylases (Hdacs) are conserved enzymes that remove acetyl groups from lysine side chains in histones and other proteins. Eleven of the 18 Hdacs encoded by the human and mouse genomes depend on Zn2+for enzymatic activity, while the other 7, the sirtuins (Sirts), require NAD2+. Collectively, Hdacs and Sirts regulate numerous cellular and mitochondrial processes including gene transcription, DNA repair, protein stability, cytoskeletal dynamics, and signaling pathways to affect both development and aging. Of clinical relevance, Hdacs inhibitors are United States Food and Drug Administration-approved cancer therapeutics and are candidate therapies for other common diseases including arthritis, diabetes, epilepsy, heart disease, HIV infection, neurodegeneration, and numerous aging-related disorders. Hdacs and Sirts influence skeletal development, maintenance of mineral density and bone strength by affecting intramembranous and endochondral ossification, as well as bone resorption. With few exceptions, inhibition of Hdac or Sirt activity though either loss-of-function mutations or prolonged chemical inhibition has negative and/or toxic effects on skeletal development and bone mineral density. Specifically, Hdac/Sirt suppression causes abnormalities in physiological development such as craniofacial dimorphisms, short stature, and bone fragility that are associated with several human syndromes or diseases. In contrast, activation of Sirts may protect the skeleton from aging and immobilization-related bone loss. This knowledge may prolong healthspan and prevent adverse events caused by epigenetic therapies that are entering the clinical realm at an unprecedented rate. In this review, we summarize the general properties of Hdacs/Sirts and the research that has revealed their essential functions in bone forming cells (e.g., osteoblasts and chondrocytes) and bone resorbing osteoclasts. Finally, we offer predictions on future research in this area and the utility of this knowledge for orthopedic applications and bone tissue engineering.